Oxford’s clinical experience in the development of high intensity focused ultrasound therapy

References

• Kennedy JE, Ter Haar GR, Cranston D. High intensity focused ultrasound: surgery of the future? Br J Radiol. 2003;76:590–599.
   PubMed Web of Science ®Google Scholar
• Izadifar Z, Chapman D, Babyn P. An introduction to high intensity focused ultrasound: systematic review on principles, devices, and clinical applications. J Clin Med. 2020; 9:460.
   PubMed Web of Science ®Google Scholar
• Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer. 2005;5:321–327.
   PubMed Web of Science ®Google Scholar
• Kennedy JE, Wu F, Ter Haar GR, Gleeson F V., Phillips RR, Middleton MR, Cranston D. High-intensity focused ultrasound for the treatment of liver tumours. Ultrasonics. 2004;42:931–935.
   PubMed Web of Science ®Google Scholar
• Kennedy JE, Ter Haar GR, Wu F, Gleeson F V., Roberts ISD, Middleton MR, Cranston D. Contrast-enhanced ultrasound assessment of tissue response to high-intensity focused ultrasound. Ultrasound Med Biol. 2004;30:851–854.
   PubMed Web of Science ®Google Scholar
• ter Haar G, Coussios C. High intensity focused ultrasound: physical principles and devices. Int J Hyperth. 2007; 23:89–104.
   PubMed Web of Science ®Google Scholar
• Oosterhof GON, Cornel EB, Smits GAHJ, Debruyne FMJ, Schalken JA. Influence of high-intensity focused ultrasound on the development of metastases. Eur Urol. 1997;32:91–95.
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Lu P, Xu ZL, Chen WZ, Zhu H, et al. Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med Biol. 2004;30:1217–1222.
   PubMed Web of Science ®Google Scholar
• Kepp O, Marabelle A, Zitvogel L, Kroemer G. Oncolysis without viruses – inducing systemic anticancer immune responses with local therapies. Nat Rev Clin Oncol. 2020;17:49–64.
   PubMed Web of Science ®Google Scholar
• Den Brok MHMGM, Sutmuller RPM, Van Der Voort R, Bennink EJ, Figdor CG, Ruers TJM, et al. In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res. 2004; 64:4024–4029.
   PubMed Web of Science ®Google Scholar
• Gillies MJ, Lyon PC, Wu F, Leslie T, Chung DY, Gleeson F, et al. High-intensity focused ultrasonic ablation of sacral chordoma is feasible: a series of four cases and details of a national clinical trial. Br J Neurosurg. 2017;31:446–451.
   PubMed Web of Science ®Google Scholar
• Cranston D. High intensity focused ultrasound. Sci Omega Rev UK. 2014.
   Google Scholar
• Ter Haari G, Sinnetts D, Rivensi I. High intensity focused ultrasound-a surgical technique for the treatment of discrete liver tumours. Phys Med Biol. 1989;34:1743–1750.
   PubMed Web of Science ®Google Scholar
• Cranston D. A review of high intensity focused ultrasound in relation to the treatment of renal tumours and other malignancies. Ultrason Sonochem. 2015;27:654–658.
   PubMed Web of Science ®Google Scholar
• Leslie T, Ritchie R, Illing R, Ter Haar G, Phillips R, Middleton M, et al. High-intensity focused ultrasound treatment of liver tumours: post-treatment MRI correlates well with intra-operative estimates of treatment volume. Br J Radiol. 2012;85:1363–1370.
   PubMed Web of Science ®Google Scholar
• Illing RO, Kennedy JE, Wu F, Ter Haar GR, Protheroe AS, Friend PJ, et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer. 2005;93:890–895.
   PubMed Web of Science ®Google Scholar
• Leslie TA, Kennedy JE, Illing RO, Haar GRT, Wu F, Phillips RR, et al. High-intensity focused ultrasound ablation of liver tumours: can radiological assessment predict the histological response? Br J Radiol. 2008;81:564–571.
   PubMed Web of Science ®Google Scholar
• Ritchie RW, Leslie T, Phillips R, Wu F, Illing R, Ter Haar G, et al. Extracorporeal high intensity focused ultrasound for renal tumours: a 3-year follow-up. BJU Int. 2010; 106:1004–9.
   PubMed Web of Science ®Google Scholar
• Marberger M, Schatzl G, Cranston D, Kennedy JE. Extracorporeal ablation of renal tumours with high-intensity focused ultrasound. BJU Int Suppl. 2005;52–55.
   PubMed Web of Science ®Google Scholar
• Chakera A, Leslie T, Roberts I, O’Callaghan CA, Cranston D. A lucky fall? Case report. Transplant Proc. 2010; 42:3883–3886.
   PubMed Web of Science ®Google Scholar
• Ritchie R, Collin J, Coussios C, Leslie T. Attenuation and de-focusing during high-intensity focused ultrasound therapy through peri-nephric fat. Ultrasound Med Biol. 2013;39:1785–1793.
   PubMed Web of Science ®Google Scholar
• Dickinson L, Ahmed HU, Kirkham AP, Allen C, Freeman A, Barber J, et al. A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study. Contemp Clin Trials. 2013; 36:68–80.
   PubMed Web of Science ®Google Scholar
• Hamdy FC, Elliott D, Le Conte S, Davies LC, Burns RM, Thomson C, et al. Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: The PART feasibility RCT. Health Technol Assess (Rockv). 2018; 22:1–96.
   Web of Science ®Google Scholar
• Lyon PC, Rai V, Price N, Shah A, Wu F, Cranston D. Ultrasound-guided high intensity focused ultrasound ablation for symptomatic uterine fibroids: preliminary clinical experience. Ultraschall der Medizin. 2020;41:550–556.
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Wang Z, McCulloch P, Hu L, Chen W, et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study. BJOG An Int J Obstet Gynaecol. 2018; 125:354–364.
   PubMed Web of Science ®Google Scholar
• Chetan MR, Lyon PC, Wu F, Phillips R, Cranston D, Gillies MJ, et al. Role of diffusion-weighted imaging in monitoring treatment response following high-intensity focused ultrasound ablation of recurrent sacral chordoma. Radiol Case Reports. 2019;14:1197–1201.
   PubMedGoogle Scholar
• Maloney E, Hwang JH. Emerging HIFU applications in cancer therapy. Int J Hyperthermia. 2015; 31:302–309.
   PubMed Web of Science ®Google Scholar
• Fry WJ, Barnard JW, Fry FJ, Krumins RF, Brennan JF. Ultrasonic lesions in the mammalian central nervous system. Science. 1955; 122: 1091.
   PubMed Web of Science ®Google Scholar
• Lyon PC, Gray MD, Mannaris C, Folkes LK, Stratford M, Campo L, et al. Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial. Lancet Oncol. 2018; 19:1027–1039.
   PubMed Web of Science ®Google Scholar
• Paverd C, Lyka E, Elbes D, Coussios C. Passive acoustic mapping of extravasation following ultrasound-enhanced drug delivery. Phys Med Biol. 2019;64: 045006.
   PubMed Web of Science ®Google Scholar
• Kwan JJ, Myers R, Coviello CM, Graham SM, Shah AR, Stride E, et al. Ultrasound-propelled nanocups for drug delivery. Small. 2015;11:5305–5314.
   PubMed Web of Science ®Google Scholar
• Qiao S, Elbes D, Boubriak O, Urban JPG, Coussios CC, Cleveland RO. Delivering focused ultrasound to intervertebral discs using time-reversal. Ultrasound Med Biol. 2019;45:2405–2416.
   PubMed Web of Science ®Google Scholar